C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/44 (2006.01) C12Q 1/34 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2535897
Human SULF genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of SULF are provided.
L'invention concerne des gènes SULF humains identifiés comme modulateurs de la voie bêta-caténine, qui constituent par conséquent des cibles thérapeutiques pour les troubles liés à une fonction bêta-caténine déficiente. L'invention concerne en outre des procédés d'identification de modulateurs de la bêta-caténine, notamment des procédés de criblage d'agents modulant l'activité des SULF.
Francis-Lang Helen
Heuer Timothy S.
Ventura Richard Benn Abegania
Winter Christopher G.
Zhang Haiguang
Bennett Jones Llp
Exelixis Inc.
LandOfFree
Sulfs as modifiers of the beta catenin pathway and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfs as modifiers of the beta catenin pathway and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfs as modifiers of the beta catenin pathway and methods... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1955120